ESSA Pharma Inc.·4

Nov 1, 11:09 AM ET

Wood David S. 4

4 · ESSA Pharma Inc. · Filed Nov 1, 2022

Insider Transaction Report

Form 4
Period: 2022-06-29
Wood David S.
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-06-29+90,00090,000 total
    Exercise: $3.60Exp: 2032-06-29Common Shares (90,000 underlying)
Footnotes (1)
  • [F1]One-fourth vests after 12 months from the date of grant with the remaining three-fourths vesting in 36 equal installments with the first installment vesting at the end of the 13th month and subsequent installments vesting every one month anniversary thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION